operator (Periotherapia Co., Ltd. の投稿者)

JP
EN

TOP Company Introduction

Company Introduction

Company Introduction Executive Introduction Company Overview

Executive Introduction Company Overview Research and Development Pipeline What's new Inquiry

JP
EN

News

TOP operator

All Funding-related Clinical Trial Progress Joint Research and Licensing Media Relations Awards and Selections Notices

2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …
2024.04.30
Joint Research and Licensing

We have signed a joint research agreemen…
2023.12.01
Awards and Selections

The project was selected for the AMED ‘D…
2023.10.30
Funding-related

The company has secured a total investme…
2023.07.25
Media Relations

Our efforts have been featured in Nikkei…
2022.03.09
Funding-related

We have secured an additional investment…

投稿のページ送り

1 2

See all announcements

Contact

For any questions or enquiries,
please contact us here

Contact

Periotherapia Co., Ltd.
2-2 Yamadaoka, Suita City, Osaka Prefecture
565-0871
TEL: +81 6-6210-8409
FAX: +81 6-6210-8346

Company Introduction Executive Introduction Company Overview Research and Development Pipeline What's new Inquiry

Copyright © 2024 Periotherapia Co.,Ltd. All Rights Reserved.